Viewing Study NCT02950766


Ignite Creation Date: 2025-12-24 @ 4:31 PM
Ignite Modification Date: 2025-12-24 @ 4:31 PM
Study NCT ID: NCT02950766
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-03-05
First Post: 2016-09-08
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: NeoVax Plus Ipilimumab in Renal Cell Carcinoma
Sponsor: Patrick Ott, MD, PhD
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module